◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › E › ENOV

Enovis Corp (ENOV) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-09-16

Enovis Corp (ENOV) operates in the MEDICAL DEVICES industry and is headquartered in Wilmington, United States with about 7,802 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, ENOV reported $2.2B in revenue and ($1.2B) in net income.

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments.

Interactive charts & full statements → Open the ENOV valuation workbench →

ENOV Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$2.3B	$2.2B	$2.1B	$1.7B	$1.6B	$1.4B	$3.1B	$3.3B	$2.2B	$3.3B	$3.6B	$4.0B	$4.6B	$4.2B	$3.9B	$693M	$542M	$525M	$605M	$506M	$394M
Gross Profit	$1.3B	$1.3B	$1.2B	$991M	$869M	$778M	$1.3B	$1.4B	$729M	$1.0B	$1.1B	$1.3B	$1.5B	$1.3B	$1.2B	$240M	$191M	$186M	$217M	$176M	$137M
Gross Margin %	57.4%	59.8%	56.0%	58.0%	55.6%	54.5%	41.9%	42.1%	33.3%	31.2%	31.4%	31.6%	32.0%	31.1%	29.4%	34.6%	35.3%	35.4%	35.9%	34.7%	34.8%
Operating Income (EBIT)	$94M	($19M)	($776M)	($66M)	($71M)	($63M)	$162M	$204M	$152M	$29M	$238M	$285M	$410M	$406M	$140M	$26M	$34M	$38M	$17M	$123M	$20M
Operating Margin %	4.1%	-0.8%	-36.8%	-3.9%	-4.5%	-4.4%	5.3%	6.1%	6.9%	0.9%	6.5%	7.2%	8.9%	9.7%	3.6%	3.7%	6.3%	7.3%	2.8%	24.3%	5.0%
Net Income	($1.1B)	($1.2B)	($825M)	($33M)	($13M)	$72M	$43M	($528M)	$140M	$151M	$128M	$168M	$392M	$179M	($64M)	$5M	$16M	$22M	($1M)	$65M	$0M
Net Margin %	-48.0%	-52.7%	-39.2%	-1.9%	-0.9%	5.0%	1.4%	-15.9%	6.4%	4.6%	3.5%	4.2%	8.5%	4.2%	-1.7%	0.7%	3.0%	4.1%	-0.1%	12.8%	0.0%
EBITDA	($717M)	($830M)	($481M)	$170M	$242M	$170M	$180M	$406M	$330M	$160M	$349M	$431M	$410M	$526M	$140M	$26M	$34M	$55M	$17M	$140M	$33M
Earnings Per Share (EPS)	$-19.40	$-20.86	$-14.93	$-0.61	$-0.25	$1.40	$0.92	$-11.58	$3.48	$3.66	$3.12	$4.03	$9.48	$5.28	$-2.13	$0.31	$1.11	$1.50	$-0.09	$8.89	$0.01
Shares Outstanding (M)	58M	57M	55M	54M	54M	51M	46M	46M	40M	41M	41M	42M	41M	34M	30M	15M	15M	14M	11M	7M	7M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ENOV Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$583M	$589M	$576M	$549M	$565M	$559M	$561M	$505M
Gross Profit	$359M	$324M	$349M	$287M	$335M	$332M	$308M	$286M
Gross Margin %	61.6%	54.9%	60.7%	52.2%	59.3%	59.5%	54.8%	56.7%
Operating Income (EBIT)	$17M	$20M	$48M	$9M	($16M)	($43M)	($665M)	($32M)
Operating Margin %	3.0%	3.4%	8.4%	1.7%	-2.9%	-7.7%	-118.5%	-6.3%
Net Income	($1M)	($9M)	($521M)	($571M)	($37M)	($56M)	($703M)	($32M)
Net Margin %	-0.2%	-1.5%	-90.4%	-104.0%	-6.5%	-10.0%	-125.4%	-6.2%
EBITDA	$87M	$93M	($425M)	($472M)	$55M	$23M	($590M)	$40M
Earnings Per Share (EPS)	$-0.02	$-0.15	$-9.17	$-10.06	$-0.65	$-0.99	$-12.05	$-0.57
Shares Outstanding (M)	58M	57M	57M	57M	57M	57M	58M	56M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ENOV Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$271M	$217M	$114M	$135M	($56M)	$356M	$302M	$131M	$226M	$219M	$247M	$304M	$386M	$362M	$164M	$57M	$62M	$38M	($32M)	$74M	($17M)
Capital Expenditures (CapEx)	$206M	$197M	$181M	$122M	$105M	$104M	$115M	$125M	$70M	$69M	$63M	$70M	$81M	$71M	$84M	$15M	$13M	$11M	$20M	$14M	$10M
Free Cash Flow (FCF)	$63M	$20M	($67M)	$13M	($161M)	$252M	$187M	$6M	$157M	$150M	$184M	$234M	$304M	$291M	$81M	$42M	$49M	$27M	($52M)	$61M	($28M)
FCF Margin %	2.7%	0.9%	-3.2%	0.8%	-10.3%	17.7%	6.1%	0.2%	7.1%	4.5%	5.0%	5.9%	6.6%	6.9%	2.1%	6.1%	9.1%	5.2%	-8.5%	12.0%	-7.0%
Dividends Paid	—	—	—	—	—	—	—	—	$1.3B	—	$897M	$2.2B	$4M	$20M	$17M	—	—	$38.5B	$39M	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ENOV Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$75M	$24M	$89M	$83M	$48M	($2M)	$88M	$54M
Capital Expenditures (CapEx)	$44M	$53M	$56M	$53M	$44M	$43M	$53M	$51M
Free Cash Flow (FCF)	$31M	($29M)	$32M	$29M	$3M	($45M)	$35M	$2M
FCF Margin %	5.3%	-4.9%	5.6%	5.3%	0.6%	-8.0%	6.3%	0.5%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ENOV Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$3.8B	$3.8B	$4.7B	$4.5B	$4.3B	$8.5B	$7.4B	$7.4B	$6.6B	$6.7B	$6.4B	$6.7B	$7.2B	$6.6B	$6.1B	$1.1B	$1.0B	$1.0B	$913M	$897M	$797M
Cash & Cash Equivalents	$13M	$36M	$48M	$36M	$24M	$680M	$101M	$110M	$245M	$262M	$222M	$197M	$305M	$311M	$482M	$75M	$61M	$50M	$29M	$48M	$8M
Total Liabilities	$2.3B	$2.3B	$2.2B	$1.1B	$823M	$3.9B	$3.8B	$3.9B	$3.1B	$3.0B	$3.3B	$3.5B	$3.9B	$3.8B	$4.0B	$899M	$806M	$804M	$746M	$843M	$791M
Total Debt (Short + Long-Term)	$1.3B	$1.3B	$1.4B	$488M	$284M	$2.1B	$2.3B	$2.4B	$1.2B	$6M	$5M	$6M	$10M	$29M	$35M	$10M	$10M	$9M	$5M	$3M	$3M
Total Shareholders' Equity	$1.5B	$1.5B	$2.6B	$3.4B	$3.4B	$4.6B	$3.5B	$3.4B	$3.3B	$3.5B	$2.9B	$3.1B	$3.1B	$2.5B	$1.9B	$189M	$216M	$199M	$167M	$53M	$6M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ENOV viewer.

Other Companies in MEDICAL DEVICES

AORT · Artivion Inc — $1 billion
PRCT · Procept Biorobotics Corp — $1 billion
LMRI · Lumexa Imaging Holdings, Inc. Common Stock — $1 billion
IRMD · Iradimed Co — $1 billion
CBLL · CeriBell, Inc — $935 million
BVS · Bioventus Inc — $882 million
INMD · InMode Ltd — $826 million
SIBN · Si-Bone Inc — $824 million

← ENOR All “E” companies ENPH →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.